_id
69130305ccc777a4e85d79da
Ticker
IPSC
Name
Century Therapeutics Inc
Exchange
NASDAQ
Address
25 North 38th Street, Philadelphia, PA, United States, 19104
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.centurytx.com
Description
Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed and refractory B-cell lymphoma. The company is also involved in the development of CNTY-308, a CD19-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 demonstrating preclinical efficacy comparable to autologous CD19 CAR-T cells for the treatment of B-cell mediated autoimmune diseases and malignancies; and CNTY-341, A CD19/CD22 dual-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 which pairs dual targeting and primary T-cell-like functionality in an allogeneic cell with the goal of providing a differentiated therapy for B cell malignancies that are in preclinical trial. In addition, it develops solid tumor CAR iT program exploiting Nectin-4 CAR and other validated targets, engineered with Allo-Evasion 5.0 and additional engineering aimed at overcoming the key barriers to success in solid tumors, as well as non-immune effector. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Last Close
0.5916
Volume
246952
Current Price
0.5577
Change
-5.730223123732258
Last Updated
2025-12-01T09:26:02.106Z
Image
data:image/webp;base64,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
Ipo Date
2021-06-18T00:00:00.000Z
Market Cap
47608556
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.489525
Sentiment Sources
4
Rating
4.3333
Target Price
3
Strong Buy
3
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
3129000
Gross Profit
-3129000
Operating Expenses
25993000
Operating Income
-29122000
Interest Expense
-
Pretax Income
-34422000
Net Income
-34422000
Eps
-0.3981075791647365
Dividends Per Share
-
Shares Outstanding
87307091
Income Tax Expense
-
EBITDA
-31293000
Operating Margin
-
Total Other Income Expense Net
-5300000
Cash
55515000
Short Term Investments
77234000
Receivables
484000
Inventories
-
Total Current Assets
137709000
Property Plant Equipment
70281000
Total Assets
244717000
Payables
2617000
Short Term Debt
3772000
Long Term Debt
-
Total Liabilities
68369000
Equity
176348000
Depreciation
3129000
Change In Working Capital
-795000
Cash From Operations
-25584000
Capital Expenditures
195000
Cash From Investing
24671000
Cash From Financing
0
Net Change In Cash
-913000
PE
-
PB
0.2734423390579989
ROE
-19.519359448363463
ROA
-14.066043634075278
FCF
-25779000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
7
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
3129000
Quarters > 0 > income Statement > gross Profit
-3129000
Quarters > 0 > income Statement > operating Expenses
25993000
Quarters > 0 > income Statement > operating Income
-29122000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-34422000
Quarters > 0 > income Statement > net Income
-34422000
Quarters > 0 > income Statement > eps
-0.3981075791647365
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
86464066
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-31293000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-5300000
Quarters > 0 > balance Sheet > cash
55515000
Quarters > 0 > balance Sheet > short Term Investments
77234000
Quarters > 0 > balance Sheet > receivables
484000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
137709000
Quarters > 0 > balance Sheet > property Plant Equipment
70281000
Quarters > 0 > balance Sheet > total Assets
244717000
Quarters > 0 > balance Sheet > payables
2617000
Quarters > 0 > balance Sheet > short Term Debt
3772000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
68369000
Quarters > 0 > balance Sheet > equity
176348000
Quarters > 0 > cash Flow > net Income
-34428000
Quarters > 0 > cash Flow > depreciation
3129000
Quarters > 0 > cash Flow > change In Working Capital
-795000
Quarters > 0 > cash Flow > cash From Operations
-25584000
Quarters > 0 > cash Flow > capital Expenditures
195000
Quarters > 0 > cash Flow > cash From Investing
24671000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-913000
Quarters > 0 > ratios > PE
-0.3981075791647365
Quarters > 0 > ratios > PB
0.2734423390579989
Quarters > 0 > ratios > ROE
-19.519359448363463
Quarters > 0 > ratios > ROA
-14.066043634075278
Quarters > 0 > ratios > FCF
-25779000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
3201000
Quarters > 1 > income Statement > gross Profit
-3201000
Quarters > 1 > income Statement > operating Expenses
31080000
Quarters > 1 > income Statement > operating Income
-34281000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-32540999
Quarters > 1 > income Statement > net Income
-32540999
Quarters > 1 > income Statement > eps
-0.37733907678190065
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
86238084
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-29340000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1740000
Quarters > 1 > balance Sheet > cash
56878000
Quarters > 1 > balance Sheet > short Term Investments
98965000
Quarters > 1 > balance Sheet > receivables
626000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
160169000
Quarters > 1 > balance Sheet > property Plant Equipment
84386000
Quarters > 1 > balance Sheet > total Assets
284692000
Quarters > 1 > balance Sheet > payables
3208000
Quarters > 1 > balance Sheet > short Term Debt
4894000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
74794000
Quarters > 1 > balance Sheet > equity
209898000
Quarters > 1 > cash Flow > net Income
-32541000
Quarters > 1 > cash Flow > depreciation
3201000
Quarters > 1 > cash Flow > change In Working Capital
-466000
Quarters > 1 > cash Flow > cash From Operations
-27592000
Quarters > 1 > cash Flow > capital Expenditures
317000
Quarters > 1 > cash Flow > cash From Investing
32539000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
4947000
Quarters > 1 > ratios > PE
-0.37733907678190065
Quarters > 1 > ratios > PB
0.22913500579710144
Quarters > 1 > ratios > ROE
-15.503243956588438
Quarters > 1 > ratios > ROA
-11.430247074030882
Quarters > 1 > ratios > FCF
-27909000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
109164000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
109164000
Quarters > 2 > income Statement > operating Expenses
34988000
Quarters > 2 > income Statement > operating Income
74176000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
76560000
Quarters > 2 > income Statement > net Income
76560000
Quarters > 2 > income Statement > eps
0.8892128687917747
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
86098619
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
77397000
Quarters > 2 > income Statement > operating Margin
67.94914074236928
Quarters > 2 > income Statement > total Other Income Expense Net
2384000
Quarters > 2 > balance Sheet > cash
51865000
Quarters > 2 > balance Sheet > short Term Investments
113256000
Quarters > 2 > balance Sheet > receivables
983000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
169631000
Quarters > 2 > balance Sheet > property Plant Equipment
87764000
Quarters > 2 > balance Sheet > total Assets
315609000
Quarters > 2 > balance Sheet > payables
3573000
Quarters > 2 > balance Sheet > short Term Debt
4882000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
75170000
Quarters > 2 > balance Sheet > equity
240439000
Quarters > 2 > cash Flow > net Income
76560000
Quarters > 2 > cash Flow > depreciation
3221000
Quarters > 2 > cash Flow > change In Working Capital
-116212000
Quarters > 2 > cash Flow > cash From Operations
-34623000
Quarters > 2 > cash Flow > capital Expenditures
475000
Quarters > 2 > cash Flow > cash From Investing
27930000
Quarters > 2 > cash Flow > cash From Financing
120000
Quarters > 2 > cash Flow > net Change In Cash
-6573000
Quarters > 2 > ratios > PE
0.8892128687917747
Quarters > 2 > ratios > PB
0.19970636966673458
Quarters > 2 > ratios > ROE
31.841756121095166
Quarters > 2 > ratios > ROA
24.257863368915338
Quarters > 2 > ratios > FCF
-35098000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.321516250778645
Quarters > 2 > health Score
73
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4173000
Quarters > 3 > income Statement > cost Of Revenue
3318000
Quarters > 3 > income Statement > gross Profit
4173000
Quarters > 3 > income Statement > operating Expenses
41457000
Quarters > 3 > income Statement > operating Income
-37284000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-34297000
Quarters > 3 > income Statement > net Income
-36073000
Quarters > 3 > income Statement > eps
-0.4586583334009333
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
78648958
Quarters > 3 > income Statement > income Tax Expense
1776000
Quarters > 3 > income Statement > EBITDA
-30979000
Quarters > 3 > income Statement > operating Margin
-893.4579439252337
Quarters > 3 > income Statement > total Other Income Expense Net
2987000
Quarters > 3 > balance Sheet > cash
58441000
Quarters > 3 > balance Sheet > short Term Investments
130851000
Quarters > 3 > balance Sheet > receivables
1520000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
194051000
Quarters > 3 > balance Sheet > property Plant Equipment
90847000
Quarters > 3 > balance Sheet > total Assets
353216000
Quarters > 3 > balance Sheet > payables
3075000
Quarters > 3 > balance Sheet > short Term Debt
4870000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
191854000
Quarters > 3 > balance Sheet > equity
161362000
Quarters > 3 > cash Flow > net Income
-36073000
Quarters > 3 > cash Flow > depreciation
3318000
Quarters > 3 > cash Flow > change In Working Capital
1830000
Quarters > 3 > cash Flow > cash From Operations
-24223000
Quarters > 3 > cash Flow > capital Expenditures
154000
Quarters > 3 > cash Flow > cash From Investing
30606000
Quarters > 3 > cash Flow > cash From Financing
-602000
Quarters > 3 > cash Flow > net Change In Cash
5781000
Quarters > 3 > ratios > PE
-0.4586583334009333
Quarters > 3 > ratios > PB
0.2718268481835872
Quarters > 3 > ratios > ROE
-22.355325293439595
Quarters > 3 > ratios > ROA
-10.21273102011234
Quarters > 3 > ratios > FCF
-24377000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.841600766834412
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
6589000
Annuals > 0 > income Statement > cost Of Revenue
13304000
Annuals > 0 > income Statement > gross Profit
6589000
Annuals > 0 > income Statement > operating Expenses
144726000
Annuals > 0 > income Statement > operating Income
-138137000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-124776000
Annuals > 0 > income Statement > net Income
-126566000
Annuals > 0 > income Statement > eps
-1.6092520895191007
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
78648958
Annuals > 0 > income Statement > income Tax Expense
1790000
Annuals > 0 > income Statement > EBITDA
-111472000
Annuals > 0 > income Statement > operating Margin
-2096.4789801183792
Annuals > 0 > income Statement > total Other Income Expense Net
13361000
Annuals > 0 > balance Sheet > cash
58441000
Annuals > 0 > balance Sheet > short Term Investments
130851000
Annuals > 0 > balance Sheet > receivables
1520000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
194051000
Annuals > 0 > balance Sheet > property Plant Equipment
90847000
Annuals > 0 > balance Sheet > total Assets
353216000
Annuals > 0 > balance Sheet > payables
3075000
Annuals > 0 > balance Sheet > short Term Debt
4870000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
191854000
Annuals > 0 > balance Sheet > equity
161362000
Annuals > 0 > cash Flow > net Income
-126566000
Annuals > 0 > cash Flow > depreciation
13304000
Annuals > 0 > cash Flow > change In Working Capital
-9278000
Annuals > 0 > cash Flow > cash From Operations
-110135000
Annuals > 0 > cash Flow > capital Expenditures
154000
Annuals > 0 > cash Flow > cash From Investing
47482000
Annuals > 0 > cash Flow > cash From Financing
74563000
Annuals > 0 > cash Flow > net Change In Cash
11910000
Annuals > 0 > ratios > PE
-1.6092520895191007
Annuals > 0 > ratios > PB
0.2657830021777122
Annuals > 0 > ratios > ROE
-78.43606301359675
Annuals > 0 > ratios > ROA
-35.83246512049284
Annuals > 0 > ratios > FCF
-110289000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-16.738351798451966
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2235000
Annuals > 1 > income Statement > cost Of Revenue
13044000
Annuals > 1 > income Statement > gross Profit
2235000
Annuals > 1 > income Statement > operating Expenses
148781000
Annuals > 1 > income Statement > operating Income
-146546000
Annuals > 1 > income Statement > interest Expense
540000
Annuals > 1 > income Statement > pretax Income
-134792000
Annuals > 1 > income Statement > net Income
-136673000
Annuals > 1 > income Statement > eps
-2.3042132323069198
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
59314389
Annuals > 1 > income Statement > income Tax Expense
1881000
Annuals > 1 > income Statement > EBITDA
-121208000
Annuals > 1 > income Statement > operating Margin
-6556.868008948545
Annuals > 1 > income Statement > total Other Income Expense Net
11754000
Annuals > 1 > balance Sheet > cash
47324000
Annuals > 1 > balance Sheet > short Term Investments
125414000
Annuals > 1 > balance Sheet > receivables
665000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
176994000
Annuals > 1 > balance Sheet > property Plant Equipment
92081000
Annuals > 1 > balance Sheet > total Assets
360691000
Annuals > 1 > balance Sheet > payables
2741000
Annuals > 1 > balance Sheet > short Term Debt
1513000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
175941000
Annuals > 1 > balance Sheet > equity
184750000
Annuals > 1 > cash Flow > net Income
-136673000
Annuals > 1 > cash Flow > depreciation
13044000
Annuals > 1 > cash Flow > change In Working Capital
9380000
Annuals > 1 > cash Flow > cash From Operations
-88348000
Annuals > 1 > cash Flow > capital Expenditures
13736000
Annuals > 1 > cash Flow > cash From Investing
61132000
Annuals > 1 > cash Flow > cash From Financing
-9725000
Annuals > 1 > cash Flow > net Change In Cash
-36941000
Annuals > 1 > ratios > PE
-2.3042132323069198
Annuals > 1 > ratios > PB
0.17506975004979702
Annuals > 1 > ratios > ROE
-73.97726657645467
Annuals > 1 > ratios > ROA
-37.89199065127769
Annuals > 1 > ratios > FCF
-102084000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-45.6751677852349
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
5199000
Annuals > 2 > income Statement > cost Of Revenue
10071000
Annuals > 2 > income Statement > gross Profit
5199000
Annuals > 2 > income Statement > operating Expenses
139030000
Annuals > 2 > income Statement > operating Income
-133831000
Annuals > 2 > income Statement > interest Expense
1105000
Annuals > 2 > income Statement > pretax Income
-130841000
Annuals > 2 > income Statement > net Income
-130932000
Annuals > 2 > income Statement > eps
-2.266991449973147
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
57755842
Annuals > 2 > income Statement > income Tax Expense
91000
Annuals > 2 > income Statement > EBITDA
-121201000
Annuals > 2 > income Statement > operating Margin
-2574.1681092517792
Annuals > 2 > income Statement > total Other Income Expense Net
2990000
Annuals > 2 > balance Sheet > cash
84265000
Annuals > 2 > balance Sheet > short Term Investments
231233000
Annuals > 2 > balance Sheet > receivables
780000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
319721000
Annuals > 2 > balance Sheet > property Plant Equipment
111730000
Annuals > 2 > balance Sheet > total Assets
486544000
Annuals > 2 > balance Sheet > payables
5454000
Annuals > 2 > balance Sheet > short Term Debt
6977000
Annuals > 2 > balance Sheet > long Term Debt
3739000
Annuals > 2 > balance Sheet > total Liabilities
183806000
Annuals > 2 > balance Sheet > equity
302738000
Annuals > 2 > cash Flow > net Income
-130932000
Annuals > 2 > cash Flow > depreciation
8440000
Annuals > 2 > cash Flow > change In Working Capital
123945000
Annuals > 2 > cash Flow > cash From Operations
14052000
Annuals > 2 > cash Flow > capital Expenditures
30604000
Annuals > 2 > cash Flow > cash From Investing
-13128000
Annuals > 2 > cash Flow > cash From Financing
27158000
Annuals > 2 > cash Flow > net Change In Cash
28082000
Annuals > 2 > ratios > PE
-2.266991449973147
Annuals > 2 > ratios > PB
0.10403140881752539
Annuals > 2 > ratios > ROE
-43.24927825380362
Annuals > 2 > ratios > ROA
-26.91061856687165
Annuals > 2 > ratios > FCF
-16552000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-3.183689170994422
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1058000
Annuals > 3 > income Statement > cost Of Revenue
4582000
Annuals > 3 > income Statement > gross Profit
-4582000
Annuals > 3 > income Statement > operating Expenses
90301000
Annuals > 3 > income Statement > operating Income
-94883000
Annuals > 3 > income Statement > interest Expense
1275000
Annuals > 3 > income Statement > pretax Income
-95781000
Annuals > 3 > income Statement > net Income
-95824000
Annuals > 3 > income Statement > eps
-1.7420796089876285
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
55005523
Annuals > 3 > income Statement > income Tax Expense
43000
Annuals > 3 > income Statement > EBITDA
-89924000
Annuals > 3 > income Statement > operating Margin
-8968.147448015123
Annuals > 3 > income Statement > total Other Income Expense Net
-898000
Annuals > 3 > balance Sheet > cash
56445000
Annuals > 3 > balance Sheet > short Term Investments
166434000
Annuals > 3 > balance Sheet > receivables
250000
Annuals > 3 > balance Sheet > inventories
-250000
Annuals > 3 > balance Sheet > total Current Assets
228154000
Annuals > 3 > balance Sheet > property Plant Equipment
69821000
Annuals > 3 > balance Sheet > total Assets
437375000
Annuals > 3 > balance Sheet > payables
7596000
Annuals > 3 > balance Sheet > short Term Debt
1654000
Annuals > 3 > balance Sheet > long Term Debt
8903000
Annuals > 3 > balance Sheet > total Liabilities
41137000
Annuals > 3 > balance Sheet > equity
396238000
Annuals > 3 > cash Flow > net Income
-95824000
Annuals > 3 > cash Flow > depreciation
3748000
Annuals > 3 > cash Flow > change In Working Capital
-2797000
Annuals > 3 > cash Flow > cash From Operations
-89002000
Annuals > 3 > cash Flow > capital Expenditures
44970000
Annuals > 3 > cash Flow > cash From Investing
-298338000
Annuals > 3 > cash Flow > cash From Financing
417774000
Annuals > 3 > cash Flow > net Change In Cash
30434000
Annuals > 3 > ratios > PE
-1.7420796089876285
Annuals > 3 > ratios > PB
0.07569822099823843
Annuals > 3 > ratios > ROE
-24.183445303075423
Annuals > 3 > ratios > ROA
-21.908888253786795
Annuals > 3 > ratios > FCF
-133972000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-126.62759924385634
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.3981075791647365
Valuation > metrics > PB
0.2734423390579989
Valuation > final Score
70
Valuation > verdict
72.7% Undervalued
Profitability > metrics > ROE
-19.519359448363463
Profitability > metrics > ROA
-24.996187613010044
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3876936511896931
Risk > metrics > Interest Coverage
-9.307126877596676
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
21.554077320394427
Liquidity > metrics > Quick Ratio
21.554077320394427
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
90
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
100
Prev Profitabilities > 2
0
Prev Risks > 0
17
Prev Risks > 1
100
Prev Risks > 2
-15
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:41:02.073Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.3267
Earnings History > 0 > eps Difference
0.3267
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.3199
Earnings History > 1 > eps Estimate
-0.3867
Earnings History > 1 > eps Difference
0.0668
Earnings History > 1 > surprise Percent
17.2744
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-14
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.38
Earnings History > 2 > eps Estimate
-0.38
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
0
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-16
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.89
Earnings History > 3 > eps Estimate
-0.07
Earnings History > 3 > eps Difference
0.96
Earnings History > 3 > surprise Percent
1371.4286
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-19
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.41
Earnings History > 4 > eps Estimate
-0.415
Earnings History > 4 > eps Difference
0.005
Earnings History > 4 > surprise Percent
1.2048
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.37
Earnings History > 5 > eps Estimate
-0.4507
Earnings History > 5 > eps Difference
0.0807
Earnings History > 5 > surprise Percent
17.9055
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.38
Earnings History > 6 > eps Estimate
-0.45
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
15.5556
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.45
Earnings History > 7 > eps Estimate
-0.5
Earnings History > 7 > eps Difference
0.05
Earnings History > 7 > surprise Percent
10
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.65
Earnings History > 8 > eps Estimate
-0.55
Earnings History > 8 > eps Difference
-0.1
Earnings History > 8 > surprise Percent
-18.1818
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.55
Earnings History > 9 > eps Estimate
-0.51
Earnings History > 9 > eps Difference
-0.04
Earnings History > 9 > surprise Percent
-7.8431
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.56
Earnings History > 10 > eps Estimate
-0.54
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-3.7037
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.53
Earnings History > 11 > eps Estimate
-0.52
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-1.9231
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-16
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-2.27
Earnings History > 12 > eps Estimate
-0.59
Earnings History > 12 > eps Difference
-1.68
Earnings History > 12 > surprise Percent
-284.7458
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.53
Earnings History > 13 > eps Estimate
-0.59
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
10.1695
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.54
Earnings History > 14 > eps Estimate
-0.52
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-3.8462
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.66
Earnings History > 15 > eps Estimate
-0.45
Earnings History > 15 > eps Difference
-0.21
Earnings History > 15 > surprise Percent
-46.6667
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-17
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.24
Earnings History > 16 > eps Estimate
-0.48
Earnings History > 16 > eps Difference
0.24
Earnings History > 16 > surprise Percent
50
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.48
Earnings History > 17 > eps Estimate
-0.4
Earnings History > 17 > eps Difference
-0.08
Earnings History > 17 > surprise Percent
-20
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-12
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.93
Earnings History > 18 > eps Estimate
-0.42
Earnings History > 18 > eps Difference
-1.51
Earnings History > 18 > surprise Percent
-359.5238
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-21
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-2.39
Earnings History > 19 > eps Estimate
-0.44
Earnings History > 19 > eps Difference
-1.95
Earnings History > 19 > surprise Percent
-443.1818
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.9517
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.9517
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.5138
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.5138
Earnings History > 21 > surprise Percent
-
Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed and refractory B-cell lymphoma. The company is also involved in the development of CNTY-308, a CD19-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 demonstrating preclinical efficacy comparable to autologous CD19 CAR-T cells for the treatment of B-cell mediated autoimmune diseases and malignancies; and CNTY-341, A CD19/CD22 dual-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 which pairs dual targeting and primary T-cell-like functionality in an allogeneic cell with the goal of providing a differentiated therapy for B cell malignancies that are in preclinical trial. In addition, it develops solid tumor CAR iT program exploiting Nectin-4 CAR and other validated targets, engineered with Allo-Evasion 5.0 and additional engineering aimed at overcoming the key barriers to success in solid tumors, as well as non-immune effector. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$3
Analyst Picks
Strong Buy
3
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 28.04% of the total shares of Century Therapeutics Inc
1.
Bain Capital Life Sciences Investors, LLC(6.2628%)
since
2025/06/30
2.
Vanguard Group Inc(2.4425%)
since
2025/06/30
3.
Renaissance Technologies Corp(2.3412%)
since
2025/06/30
4.
Dafna Capital Management LLC(1.9727%)
since
2025/06/30
5.
Vanguard Total Stock Mkt Idx Inv(1.4892%)
since
2025/07/31
6.
Casdin Capital, LLC(1.4217%)
since
2025/06/30
7.
Syncona Portfolio Ltd.(1.4042%)
since
2025/06/30
8.
FMR Inc(1.1814%)
since
2025/06/30
9.
BlackRock Inc(1.0704%)
since
2025/06/30
10.
TANG CAPITAL MANAGEMENT LLC(1.0418%)
since
2025/06/30
11.
Millennium Management LLC(0.9402%)
since
2025/06/30
12.
Two Sigma Investments LLC(0.6628%)
since
2025/06/30
13.
Vanguard Institutional Extnd Mkt Idx Tr(0.6247%)
since
2025/07/31
14.
GSA Capital Partners LLP(0.5401%)
since
2025/06/30
15.
SUPERSTRING CAPITAL MANAGEMENT LP(0.5359%)
since
2025/06/30
16.
Jane Street Group LLC(0.5146%)
since
2025/06/30
17.
Geode Capital Management, LLC(0.4402%)
since
2025/06/30
18.
Two Sigma Advisers, LLC(0.4249%)
since
2025/06/30
19.
Goldman Sachs Group Inc(0.3195%)
since
2025/06/30
20.
Susquehanna International Group, LLP(0.2315%)
since
2025/06/30
21.
Fidelity Extended Market Index(0.2205%)
since
2025/07/31
22.
Citadel Advisors Llc(0.2159%)
since
2025/06/30
23.
Fidelity Growth Compy Commingled Pl S(0.2075%)
since
2025/07/31
24.
Fidelity Growth Company K6(0.2035%)
since
2025/07/31
25.
Charles Schwab Investment Management Inc(0.1891%)
since
2025/06/30
26.
Schwab US Small-Cap ETFâ„¢(0.189%)
since
2025/08/30
27.
Fidelity Global Micro-Cap F(0.1736%)
since
2025/06/30
28.
Galileo - Biotech Innovation Fund S USD(0.1445%)
since
2025/02/28
29.
Extended Equity Market Fund K(0.1129%)
since
2025/06/30
30.
Fidelity Total Market Index(0.0746%)
since
2025/07/31
31.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0583%)
since
2025/03/31
32.
Fidelity Series Total Market Index(0.0551%)
since
2025/07/31
33.
Northern Trust Extended Eq Market Idx(0.054%)
since
2025/06/30
34.
NT Ext Equity Mkt Idx Fd - L(0.054%)
since
2025/06/30
35.
PGIM Quantitative Solutions US Micro Cap(0.0526%)
since
2025/06/30
36.
Goldman Sachs Absolute Ret Trckr Instl(0.0482%)
since
2025/06/30
37.
Spartan Extended Market Index Pool F(0.0439%)
since
2025/07/31
38.
State Street Russell 2000 Value CIT(0.0349%)
since
2025/03/31
39.
Spartan Total Market Index Pool G(0.0278%)
since
2025/07/31
40.
Russell 2000 Index Non-Lendable Fund E(0.0227%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.3267
Date
2025-09-30
EPS Actual
-0.3199
EPS Estimate
-0.3867
EPS Difference
0.0668
Surprise Percent
17.2744%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.